Fig. 2
From: Evaluation of new and old biomarkers in dogs with degenerative mitral valve disease
ST2 concentrations in ng/mL for each dog in the respective groups at a) baseline and b) follow-up examination, median marked as a bar. No significant differences between the groups could be detected. Significant changes in ST2 concentrations from baseline (1) to follow-up (2) examination occurred in c) control group and d) initially in stage B1 patients. * p < 0.05, ** p < 0.001